ANAB Revenue Flow Filed revenue amounts for 2026-01-01 to 2026-03-31. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-03-31: Revenue $25.56M ; Revenue including tax (m) ; Research and development (m) ; Operating expenses $60.19M . 2025-09-30: Revenue $76.32M ; Revenue including tax (m) ; Research and development $31.41M ; Operating expenses $41.62M . 2025-06-30: Revenue $22.26M ; Revenue including tax (m) ; Research and development $37.82M ; Operating expenses $48.43M . 2025-03-31: Revenue $27.77M ; Revenue including tax (m) ; Research and development $41.18M ; Operating expenses $55.31M . Segment Separate filed amounts; connecting flows are not established. Components and totals may overlap.
ANAB revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Biopharma Company $0.00 Royalty Management Company $25.56M Revenue $25.56M Operating expenses $60.19M Operating income -$34.64M Other income, net -$1.00K Pre-tax income -$52.84M Income tax $40.00K Net income -$52.88M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Revenue including tax Research and development Operating expenses Income tax Net income 2026-03-31 $25.56M (m) (m) $60.19M $40.00K -$52.88M 2025-09-30 $76.32M (m) $31.41M $41.62M $0.00 $15.11M 2025-06-30 $22.26M (m) $37.82M $48.43M $39.00K -$38.63M 2025-03-31 $27.77M (m) $41.18M $55.31M $44.00K -$39.33M 2024-09-30 $30.02M (m) $42.21M $52.77M $0.00 -$32.85M 2024-06-30 $10.97M (m) $42.00M $51.29M $9.00K -$46.66M 2024-03-31 $7.18M (m) $37.04M $49.38M $0.00 -$43.94M 2023-09-30 $3.32M (m) $30.88M $41.05M $0.00 -$37.31M 2023-06-30 $3.46M (m) $32.92M $43.60M (m) -$39.84M 2023-03-31 $1.37M (m) $34.96M $45.77M (m) -$44.26M 2022-09-30 $1.29M (m) $22.06M $30.93M (m) -$33.50M 2022-06-30 $1.22M (m) $20.84M $29.02M (m) -$32.55M 2022-03-31 $970.00K (m) $22.52M $32.72M (m) -$36.26M 2021-09-30 $20.89M (m) $22.22M $27.65M (m) -$6.67M 2021-06-30 $30.03M (m) $25.31M $30.56M (m) -$429.00K 2021-03-31 $11.25M (m) $24.18M $29.61M (m) -$18.16M 2020-09-30 $0.00 (m) $19.54M $24.34M $0.00 -$23.77M 2020-06-30 $0.00 (m) $17.95M $22.64M $0.00 -$21.55M 2020-03-31 $15.00M (m) $20.97M $25.25M $0.00 -$8.26M 2019-09-30 $0.00 (m) $29.93M $33.74M -$51.00K -$31.03M 2019-06-30 $5.00M (m) $27.35M $31.66M -$60.00K -$23.96M 2019-03-31 $0.00 $0.00 $20.63M $24.77M -$19.00K -$22.08M 2018-12-31 (m) $0.00* (m) (m) (m) (m) 2018-09-30 $5.00M $5.00M $17.88M $21.89M $0.00 -$15.96M 2018-06-30 $0.00 $0.00 $10.58M $14.41M $0.00 -$13.62M 2018-03-31 $0.00 $0.00 $11.81M $15.76M $0.00 -$15.09M 2017-09-30 $0.00 $0.00 $6.70M $9.09M (m) -$9.09M 2017-06-30 $7.00M $7.00M $7.21M $9.55M (m) -$2.68M 2017-03-31 $0.00 (m) $7.93M $9.99M (m) -$11.44M 2016-09-30 $3.21M (m) $3.28M $4.29M (m) -$1.11M 2016-06-30 $5.85M (m) $2.33M $3.49M (m) $2.32M 2016-03-31 $4.87M (m) $4.79M $6.00M (m) -$888.00K
Revenue and expense 6 month Period end Revenue Revenue including tax Research and development Operating expenses Income tax Net income 2026-06-30 $53.04M (m) (m) $20.72M -$181.45M $131.00M 2025-06-30 $50.03M (m) $79.00M $6.57M $83.00K -$77.96M 2024-06-30 $18.15M (m) $79.04M $100.67M $9.00K -$90.60M 2023-06-30 $4.83M (m) $67.88M $89.38M $0.00 -$84.10M 2022-06-30 $2.19M (m) $43.36M $61.73M (m) -$68.81M 2021-06-30 $41.27M (m) $49.50M $60.17M (m) -$18.59M 2020-06-30 $15.00M (m) $38.92M $47.89M $0.00 -$29.81M 2019-06-30 $5.00M (m) $47.98M $56.43M -$79.00K -$46.04M 2018-06-30 $0.00 $0.00 $22.39M $30.17M $0.00 -$28.70M 2017-06-30 $7.00M $7.00M $15.14M $19.54M (m) -$14.12M 2016-06-30 $10.72M (m) $7.12M $9.49M (m) $1.43M
Revenue and expense 9 month Period end Revenue Revenue including tax Research and development Operating expenses Income tax Net income 2025-09-30 $126.35M (m) $110.41M $145.36M $83.00K -$62.85M 2024-09-30 $48.17M (m) $121.25M $153.45M $9.00K -$123.45M 2023-09-30 $8.15M (m) $98.76M $130.43M $0.00 -$121.41M 2022-09-30 $3.48M (m) $65.42M $92.66M (m) -$102.31M 2021-09-30 $62.16M (m) $71.72M $87.82M (m) -$25.26M 2020-09-30 $15.00M (m) $58.46M $72.22M $0.00 -$53.58M 2019-09-30 $5.00M (m) $77.91M $90.17M -$130.00K -$77.07M 2018-09-30 $5.00M $5.00M $40.28M $52.06M $0.00 -$44.66M 2017-09-30 $7.00M $7.00M $21.84M $28.63M (m) -$23.21M 2016-09-30 $13.93M (m) $10.40M $13.78M (m) $319.00K
Revenue and expense 12 month Period end Revenue Revenue including tax Research and development Operating expenses Income tax Net income 2025-12-31 $234.60M (m) (m) $7.70M $772.00K -$13.23M 2024-12-31 $91.28M (m) (m) $25.13M $158.00K -$145.23M 2023-12-31 $17.16M (m) (m) $181.57M -$4.00K -$163.62M 2022-12-31 $10.29M (m) $88.80M $125.44M $24.00K -$128.72M 2021-12-31 $63.17M (m) $98.50M $119.99M $0.00 -$57.80M 2020-12-31 $75.00M (m) $80.03M $98.88M $0.00 -$19.93M 2019-12-31 $8.00M (m) $99.34M $115.43M -$152.00K -$97.34M 2018-12-31 $5.00M $5.00M $56.20M $71.72M -$192.00K -$61.66M 2017-12-31 $10.00M $10.00M $29.44M $38.78M $0.00 -$30.07M 2016-12-31 $16.68M $16.68M $15.42M $19.71M $0.00 -$4.26M 2015-12-31 $17.57M (m) $17.30M $20.89M $139.00K -$5.41M